1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Rituxumab: new trials by email Literature Review of Rituxumab trials Research Report on Rituxumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma Mosunetuzumab, Polatuzumab Vedotin, Rituxumab - B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 117 | 2019-03-08 | 2024-12-18 |
Lymphoma, B-Cell (1)
Austria (1) · France (1) · Poland (1) · South Korea (1) · Spain (1) · United States (1)
2018 (1)